OXFORD, England--(BUSINESS WIRE)--Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the appointment of a new finance director. Mr Tim Hall will join the company at the start of 2012 and brings a strong track record in financial management and strategic planning together with a broad knowledge of the biotech and healthcare industries. Mr Hall joins the OGT board at a time of rapid growth and will utilise his experience to help drive the company’s ongoing expansion and development.
